4//SEC Filing
Plovanic William J. 4
Accession 0001214659-18-002171
CIK 0001427570other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 6:15 PM ET
Size
10.7 KB
Accession
0001214659-18-002171
Insider Transaction Report
Form 4
Plovanic William J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2018-03-13$4.05/sh+9,588$38,825→ 9,588 total(indirect: By Spouse) - Purchase
Common Stock
2018-03-13$4.05/sh+9,700$39,276→ 9,700 total(indirect: By IRA) - Purchase
Common Stock
2018-03-14$4.04/sh+5,300$21,387→ 15,000 total(indirect: By IRA) - Purchase
Common Stock
2018-03-14$4.04/sh+5,412$21,843→ 15,000 total(indirect: By Spouse)
Holdings
- 190,572
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.015 to $4.05, inclusive.
- [F2]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.99 to $4.05, inclusive.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001685640
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 6:15 PM ET
- Size
- 10.7 KB